Lineage Cell Therapeutics (LCTX) Institutional Ownership $1.30 -0.02 (-1.52%) Closing price 05/22/2026 04:10 PM EasternExtended Trading$1.30 -0.01 (-0.38%) As of 05/22/2026 06:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock Institutional Ownership Changes (13F Filings) for Lineage Cell Therapeutics (NYSEAMERICAN:LCTX)CurrentInstitutional OwnershipPercentage62.47%Number ofInstitutional Buyers(last 12 months)46TotalInstitutional Inflows(last 12 months)$32.60MNumber ofInstitutional Sellers(last 12 months)17TotalInstitutional Outflows(last 12 months)$5.12M Get LCTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Lineage Cell Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data LCTX Institutional Buying and Selling by Quarter Lineage Cell Therapeutics Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2026 Bank of America Corp DE419,355$663K0.0%+112.0%0.168% 5/16/2026 SummitTX Capital L.P.60,833$96K0.0%+185.3%0.024% 5/15/2026 OMERS ADMINISTRATION Corp109,000$172K0.0%-61.5%0.044% 5/14/2026 Renaissance Technologies LLC2,125,100$3.36M0.0%-11.6%0.852% 5/14/2026 Sei Investments Co.422,274$667K0.0%+56.8%0.169% 5/1/2026 Fifth Third Bancorp4,600,000$7.27M0.0%N/A1.847% 4/28/2026 Ascentis Independent Advisors30,912$49K0.0%N/A0.012% 2/18/2026 XTX Topco Ltd42,281$71K0.0%N/A0.018% 2/18/2026 SummitTX Capital L.P.21,319$36K0.0%-71.1%0.009% 2/18/2026 Quadrature Capital Ltd30,632$51K0.0%-82.9%0.013% Get the Latest News and Ratings for LCTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lineage Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/18/2026 Millennium Management LLC2,110,419$3.52M0.0%-21.3%0.916% 2/17/2026 Jain Global LLC38,851$65K0.0%+202.3%0.017% 2/17/2026 Raffles Associates LP5,362,788$8.96M6.7%-0.5%2.328% 2/17/2026 ExodusPoint Capital Management LP181,694$303K0.0%N/A0.079% 2/16/2026 Squarepoint Ops LLC65,109$109K0.0%N/A0.028% 2/16/2026 OMERS ADMINISTRATION Corp283,200$473K0.0%N/A0.123% 2/16/2026 Barclays PLC348,510$582K0.0%+34,850,900.0%0.151% 2/13/2026 Kestra Advisory Services LLC27,747$46K0.0%+174.7%0.012% 2/13/2026 Marshall Wace LLP1,362,061$2.28M0.0%N/A0.591% 2/13/2026 DLD Asset Management LP20,000$33K0.0%N/A0.009% 2/13/2026 Hudson Bay Capital Management LP74,447$124K0.0%N/A0.032% 2/13/2026 Charles Schwab Investment Management Inc.129,909$217K0.0%-40.5%0.056% 2/13/2026 State Street Corp1,016,211$1.70M0.0%+6.3%0.441% 2/13/2026 Ieq Capital LLC23,447$39K0.0%-85.4%0.010% 2/13/2026 Wells Fargo & Company MN17,937$30K0.0%-36.3%0.008% 2/12/2026 Jane Street Group LLC1,004,794$1.68M0.0%+494.7%0.436% 2/12/2026 Renaissance Technologies LLC2,404,800$4.02M0.0%+26.2%1.044% 2/12/2026 McMillan Office Inc.216,000$361K0.0%N/A0.094% 2/10/2026 Goldman Sachs Group Inc.1,438,746$2.40M0.0%+894.5%0.625% 2/9/2026 Geode Capital Management LLC2,461,193$4.11M0.0%+1.7%1.069% 2/4/2026 Nwam LLC62,131$99K0.0%+77.5%0.027% 2/3/2026 Red Crane Wealth Management LLC597,263$997K0.8%+16.8%0.259% 1/13/2026 Define Financial LLC20,000$33K0.0%N/A0.009% 1/12/2026 Defender Capital LLC.6,829,099$11.41M3.7%N/A2.965% 1/9/2026 SG Americas Securities LLC14,789$25K0.0%N/A0.006% 11/17/2025 Millennium Management LLC2,680,003$4.53M0.0%+3.1%1.174% 11/17/2025 Bank of America Corp DE233,436$395K0.0%+126.0%0.102% 11/14/2025 Raymond James Financial Inc.90,381$153K0.0%+30.3%0.040% 11/14/2025 Equitable Holdings Inc.30,024$51K0.0%N/A0.013% 11/14/2025 Dauntless Investment Group LLC1,614,100$2.73M1.7%+33.8%0.707% One filing just changed the SpaceX IPO forever (Ad)SpaceX just filed its S-1. The IPO is confirmed for June 12 - $75 billion, ticker SPCX, potentially the largest in history. The 21-bank syndicate has already locked up shares, so retail investors won't get access. But the S-1 exposed one publicly traded company Musk cannot operate without - and it's still cheap. Dylan Jovine is releasing the ticker free before June 12 changes the price.Get the ticker before the SpaceX IPO reprices everything on June 1211/14/2025 Two Sigma Investments LP354,347$599K0.0%+11.4%0.155% 11/14/2025 Bridgeway Capital Management LLC221,000$373K0.0%+47.3%0.097% 11/13/2025Jefferies Financial Group Inc.62,200$105K0.0%N/A0.027% 11/12/2025 Dimensional Fund Advisors LP27,121$46K0.0%-33.0%0.012% 11/7/2025 GSA Capital Partners LLP670,856$1.13M0.1%-25.3%0.294% 11/7/2025Vanguard Group Inc.9,006,930$15.22M0.0%+6.2%3.944% 10/29/2025 Red Crane Wealth Management LLC511,363$864K0.7%+3.1%0.224% 10/28/2025 Nwam LLC35,000$56K0.0%+133.3%0.015% 10/24/2025 Citizens Financial Group Inc. RI15,000$25K0.0%N/A0.007% 10/24/2025ORG Partners LLC35,700$60K0.0%-39.7%0.016% 9/4/2025 Osaic Holdings Inc.81,477$74K0.0%-16.2%0.036% 8/18/2025 Hudson Bay Capital Management LP48,330$44K0.0%N/A0.021% 8/15/2025 Raffles Associates LP5,392,088$4.89M5.1%-4.4%2.361% 8/15/2025 Hudson Bay Capital Management LP48,330$44K0.0%N/A0.021% 8/15/2025 Bridgeway Capital Management LLC150,000$136K0.0%-10.7%0.066% 8/15/2025 Brevan Howard Capital Management LP308,877$281K0.0%N/A0.135% 8/15/2025 Bank of America Corp DE103,312$94K0.0%-35.8%0.045% 8/14/2025 Raymond James Financial Inc.69,380$63K0.0%+136.2%0.030% 8/14/2025 Qube Research & Technologies Ltd39,036$35K0.0%N/A0.017% 8/14/2025 WINTON GROUP Ltd76,061$69K0.0%N/A0.033% 8/13/2025 Jump Financial LLC31,060$28K0.0%N/A0.014% 8/12/2025 XTX Topco Ltd94,054$85K0.0%+117.8%0.041% 8/12/2025 Catalyst Funds Management Pty Ltd83,100$75K0.0%N/A0.036% 8/8/2025 Geode Capital Management LLC2,431,619$2.21M0.0%-45.8%1.065% 8/4/2025 Integrity Alliance LLC.35,000$32K0.0%+75.0%0.015% 8/1/2025 Y Intercept Hong Kong Ltd405,043$368K0.0%N/A0.177% 7/31/2025 Ground Swell Capital LLC104,511$95K0.2%N/A0.046% 7/29/2025 Cannon Global Investment Management LLC33,000$30K0.1%N/A0.014% 7/25/2025 Defender Capital LLC.6,785,177$6.16M2.1%+7.5%2.971% 7/16/2025ORG Partners LLC59,200$53K0.0%-48.7%0.026% 7/14/2025 Kapitalo Investimentos Ltda27,130$25K0.0%N/A0.012% 6/27/2025 Goldman Sachs Group Inc.350,103$158K0.0%-9.1%0.153% 5/29/2025Rhumbline Advisers201,447$91K0.0%+9.9%0.091% 5/19/2025Jane Street Group LLC68,068$31K0.0%-74.1%0.031% 5/16/2025Goldman Sachs Group Inc.350,103$158K0.0%-9.1%0.159% 5/16/2025Broadwood Capital Inc.49,560,992$22.38M1.8%+18.9%22.485% 5/15/2025Royal Bank of Canada528,656$237K0.0%+1,578.9%0.240% 5/15/2025MAI Capital Management64,391$29K0.0%-90.2%0.029% 5/14/2025Comerica Bank3,000,000$1.36M0.0%+275.0%1.361% 5/13/2025Cookson Peirce & Co. Inc.250,000$113K0.0%N/A0.113% 5/12/2025Nuveen LLC515,445$233K0.0%N/A0.234% 5/12/2025Red Crane Wealth Management LLC495,996$224K0.2%+45.8%0.225% 5/9/2025Charles Schwab Investment Management Inc.503,193$227K0.0%+20.9%0.228% 4/28/2025Defender Capital LLC.6,310,873$2.84M1.1%+5.8%2.863% 4/21/2025ORG Partners LLC115,400$47K0.0%N/A0.052% 2/17/2025Squarepoint Ops LLC92,001$46K0.0%N/A0.042% 2/17/2025Two Sigma Advisers LP86,964$44K0.0%+312.2%0.039% 2/17/2025Two Sigma Investments LP301,544$152K0.0%N/A0.137% 2/17/2025Jacobs Levy Equity Management Inc.1,033,763$519K0.0%N/A0.469% 2/17/2025Deutsche Bank AG174,702$87K0.0%+196.0%0.079% One filing just changed the SpaceX IPO forever (Ad)SpaceX just filed its S-1. The IPO is confirmed for June 12 - $75 billion, ticker SPCX, potentially the largest in history. The 21-bank syndicate has already locked up shares, so retail investors won't get access. But the S-1 exposed one publicly traded company Musk cannot operate without - and it's still cheap. Dylan Jovine is releasing the ticker free before June 12 changes the price.Get the ticker before the SpaceX IPO reprices everything on June 122/17/2025DAFNA Capital Management LLC2,511,374$1.26M0.3%+85.9%1.139% 2/17/2025Bridgeway Capital Management LLC417,900$210K0.0%-44.8%0.190% 2/17/2025Alyeska Investment Group L.P.3,947,369$1.98M0.0%N/A1.791% 2/14/2025Jane Street Group LLC262,866$132K0.0%+119.2%0.119% 2/14/2025Raffles Associates LP5,492,088$2.76M3.0%+21.8%2.492% 2/14/2025Comerica Bank800,000$402K0.0%+220.0%0.363% 2/13/2025Barclays PLC234,069$118K0.0%+10.8%0.106% 2/13/2025Renaissance Technologies LLC2,283,072$1.15M0.0%+1,058.3%1.036% 2/13/2025Wells Fargo & Company MN94,894$48K0.0%+33.0%0.043% 2/12/2025JPMorgan Chase & Co.946,399$476K0.0%+39.8%0.429% LCTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LCTX shares? During the previous two years, 73 institutional investors and hedge funds held shares of Lineage Cell Therapeutics. The most heavily invested institutionals were Broadwood Capital Inc. ($22.38M), Vanguard Group Inc. ($15.22M), Defender Capital LLC. ($11.41M), Raffles Associates LP ($8.96M), Fifth Third Bancorp ($7.27M), Logos Global Management LP ($4.69M), and Geode Capital Management LLC ($4.11M).Learn more on Lineage Cell Therapeutics' institutional investors. What percentage of Lineage Cell Therapeutics' stock is owned by institutional investors? 62.47% of Lineage Cell Therapeutics' stock is owned by institutional investors. Learn more on LCTX's institutional investor holdings. Which institutional investors have been buying Lineage Cell Therapeutics' stock? Of the 67 institutional investors that purchased Lineage Cell Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Defender Capital LLC. ($8.64M), Broadwood Capital Inc. ($7.89M), Fifth Third Bancorp ($4.60M), Alyeska Investment Group L.P. ($3.95M), Comerica Bank ($2.75M), Renaissance Technologies LLC ($2.64M), and Raffles Associates LP ($2.28M). How much institutional buying is happening at Lineage Cell Therapeutics? Institutional investors have bought a total of 20,605,342 shares in the last 24 months. This purchase volume represents approximately $32.60M in transactions. Which of Lineage Cell Therapeutics' major shareholders have been selling company stock? Of the 17 institutional investors that sold Lineage Cell Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Geode Capital Management LLC ($2.05M), Millennium Management LLC ($569.58K), Renaissance Technologies LLC ($279.70K), Raffles Associates LP ($275K), GSA Capital Partners LLP ($226.76K), OMERS ADMINISTRATION Corp ($174.20K), and Quadrature Capital Ltd ($148.40K). How much institutional selling is happening at Lineage Cell Therapeutics? Institutional investors have sold a total of 4,234,993 shares in the last 24 months. This volume of shares sold represents approximately $5.12M in transactions. Related Companies Septerna Major Shareholders WAVE Life Sciences Major Shareholders MoonLake Immunotherapeutics Major Shareholders Harrow Major Shareholders Maplight Therapeutics Major Shareholders Olema Pharmaceuticals Major Shareholders DBV Technologies Major Shareholders Collegium Pharmaceutical Major Shareholders Jade Biosciences Major Shareholders Maravai LifeSciences Major Shareholders This page (NYSEAMERICAN:LCTX) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredYour computer is about to become a museum pieceFuturist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredYour $29.97 book is free todayBill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...Profits Run | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredOne page of the SpaceX S-1 will move this stock overnightWhen SpaceX files its S-1 in June, the SEC will require full disclosure of operating expenses - including powe...Behind the Markets | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | SponsoredJune 12: Elon Musk’s “Day-One Retirement Plan.”SpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lineage Cell Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lineage Cell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
